
Doripenem Injectable (IV)
Form: Injectable (IV)
Strength: 500 mg, 1 g per vial
Reference Brands: Doribax(US & EU)
Category: Antibiotics
Doripenem injectable is approved in the EU and US for severe bacterial infections such as pneumonia, intra-abdominal, and urinary tract infections. In the EU, brands like Doribax are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Colistin (Polymyxin E) Inhalation Solution (Nebulizer)
Strength: 75 mg/2 mL
Form: Inhalation Solution (Nebulizer)
Reference Brands: Coly-Mycin M(US)
View Details Get EnquiryColistin (Polymyxin E)
Strength: 150 mg/5 mL, 300 mg/5 mL, 1.5 million IU/vial
Form: Injectable (IV/IM/SC)
Reference Brands: Coly-Mycin M(US)
View Details Get EnquiryFosfomycin Oral Sachets or Powder for Suspension
Strength: 3g in a sachet
Form: Oral Sachets or Powder for Suspension
Reference Brands: Zyflo(US)
View Details Get EnquiryFosfomycin IV
Strength: 2 g, 4g per vial
Form: Intravenous (IV)
Reference Brands: Zyflo(US)
View Details Get Enquiry